Corona Virus Vaccine News

Corona Virus (Covid-19) vaccine Good News:
Israel may may have the answer in weeks

Good News: JERUSALEM, Israel – Israeli scientists say they are just weeks away from releasing the world’s first vaccine against the deadly Coronavirus.

The Galilee Research Institute (MIGAL) spent four years creating a vaccine against the highly contagious coronavirus that infects birds called Infectious Bronchitis Virus (IBV). Now, they’re adapting the vaccine for the human coronavirus, also known as COVID-19.

“Congratulations to MIGAL on this exciting breakthrough. I am confident that there will be further rapid progress, enabling us to provide a needed response to the grave global COVID-19 threat,” said Israeli Minister of Science and Technology Ofir Akunis.

Akunis will fast-track the approval processes for the human coronavirus vaccine so it can hit the market as soon as possible in the form of an oral pill.

“Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days. This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion final product development and regulatory activities, “ said MIGAL CEO David Zigdon.

The poultry coronavirus is nearly identical to the human coronavirus. Israel’s vaccine for the poultry coronavirus has been proven effective against the disease in pre-clinical trials carried out by the Volcani Institute.

“The scientific framework for the vaccine is based on a new protein expression vector, which forms and secretes a chimeric soluble protein that delivers the viral antigen into mucosal tissues by self-activated endocytosis (a cellular process in which substances are brought into a cell by surrounding the material with cell membrane, forming a vesicle containing the ingested material), causing the body to form antibodies against the virus. In pre-clinical (IN-VIVO) trials, MIGAL’s researchers have demonstrated that the oral vaccination induces high levels of specific anti-IBV antibodies,” explained Dr. Chen Katz, MIGAL’s Biotechnology Group Leader.

Scientists have been scrambling to find a Coronavirus vaccine since the outbreak began infecting more than 100,000 people and killing more than 6,000 people at time of publishing this article.

MIGAL is working on safety approvals to move ahead with preclinical testing.

Source: CBN News

NEWS.NEWS reports that the church in South Africa is praying everywhere for the utter destruction of the Corona virus and for a quick vaccine to be created.

If you are on a prayer group or would like to get your church involved in a nationwide movement in which the church is standing up, whether it be against unethical laws or corona viruses, please leave your details on the News.News contact page. Put your congregation’s details in the comment section. Someone will contact you with more information. The Good News in all these uncertainties is that, as the church prays, miracles happen and circumstances change. When the Church applies the Word, Good will prevail. Acts 12: 5-11. The sooner the Church wakes up and rises to the occasion the better.

Be inspired and encouraged by uplifting music in a time of solidarity and listen to the testimony covered in the song that destroys enemies: “I raise a hallelujah” by clicking here

One can also join 24/7/365 world wide live prayers here.

Keep coming back to News.News as we will expose more in depth details regarding the Corona Virus.

In the meantime, you can learn more about News. News on our launch website:

https://launch.nuus.news

You can also find relevant current news articles by clicking on the menus at the top of the web page.

News.News we bring you news that the mainstream media will never bring you.

Newsletter!

Subscribe to the www.Nuus.News Good News letter and stay abreast of information you won't find anywhere else.

SUBSCRIBE

Leave a Reply

Your email address will not be published. Required fields are marked *